Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient

Video Credit: Geo Beats
Published on June 29, 2020 - Duration: 00:45s

Gilead's Covid-19 Drug Remdesivir To Cost $2,340-$3,120 Per Patient

Gilead Sciences announced on Monday that it has set a price for Remdesivir, a drug thatโ€™s shown success in reducing the duration of some COVID-19 cases.


You are here

Related news from verified sources

Gilead Sciences Inc (NASDAQ:GILD) has announced it will charge thousands of dollars for its investigational drug remdesivir, temporarily approved in certain...
on June 29, 2020 • Proactive Investors

Remdesivir โ€” the only drug authorized by federal regulators to treat Covid-19 patients during the pandemic โ€”ย will cost $2,340 to $3,120 for a five-day...
on June 29, 2020 • bizjournals

Gilead Sciences Inc. continued to build out its global network of manufacturers and distributors for the Covid-19-fighting drug remdesivir, signing on a large...
on June 15, 2020 • bizjournals

Related videos from verified sources

Maker of COVID-19 drug Remdesivir says it will cost about $3,000 per patient 01:47
Video credit: KSWB - Published on June 30, 2020 

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment 00:35
Video credit: Wochit Entertainment - Published on June 30, 2020 

Coronavirus: Delhi crosses 70,000 Covid-19 cases with 3,788 new patients in 24 hours | Oneindia news 02:42
Video credit: Oneindia - Published on June 24, 2020 

You might like